Cargando…
Diffuse-type tenosynovial giant cell tumor between the suboccipital bone and posterior C1 arch: illustrative case
BACKGROUND: Tenosynovial giant cell tumor (TGCT) occurs most commonly in the appendicular skeleton and is only rarely found in the vertebral column. Lesions of the craniocervical junction are particularly rare, with only 4 cases reported in the literature. The authors describe the case of a diffuse-...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association of Neurological Surgeons
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555556/ https://www.ncbi.nlm.nih.gov/pubmed/37728324 http://dx.doi.org/10.3171/CASE23288 |
_version_ | 1785116681003073536 |
---|---|
author | Porto, Carl Ayala, Cameron Feler, Joshua Santos-Fontanez, Santos Poggi, Jonathan Kritselis, Michael Doberstein, Curtis |
author_facet | Porto, Carl Ayala, Cameron Feler, Joshua Santos-Fontanez, Santos Poggi, Jonathan Kritselis, Michael Doberstein, Curtis |
author_sort | Porto, Carl |
collection | PubMed |
description | BACKGROUND: Tenosynovial giant cell tumor (TGCT) occurs most commonly in the appendicular skeleton and is only rarely found in the vertebral column. Lesions of the craniocervical junction are particularly rare, with only 4 cases reported in the literature. The authors describe the case of a diffuse-type TGCT at the craniocervical junction. OBSERVATIONS: A patient presented with a 1-year history of right-sided neck pain and bilateral neurological symptoms in the distribution of the right occipital nerve. A 20-mm homogeneously contrast-enhancing mass in the suboccipital and posterior C1 region was discovered on magnetic resonance imaging of the cervical spine. The tumor was operated on via a posterior approach, and gross-total resection (GTR) was achieved. Immunohistochemical (IHC) examination revealed a diffuse-type TGCT. The patient had an uneventful recovery. LESSONS: TGCT can arise at the craniocervical junction and is easily misdiagnosed because of its rare occurrence. IHC examination of a tumor specimen should be done to confirm the diagnosis. GTR is the objective when treating these tumors, especially when they are the diffuse type, as they have a high recurrence rate. Radiation and small-molecule therapies are viable postoperative therapies if GTR cannot be achieved or in cases of recurrence. |
format | Online Article Text |
id | pubmed-10555556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Association of Neurological Surgeons |
record_format | MEDLINE/PubMed |
spelling | pubmed-105555562023-10-07 Diffuse-type tenosynovial giant cell tumor between the suboccipital bone and posterior C1 arch: illustrative case Porto, Carl Ayala, Cameron Feler, Joshua Santos-Fontanez, Santos Poggi, Jonathan Kritselis, Michael Doberstein, Curtis J Neurosurg Case Lessons Case Lesson BACKGROUND: Tenosynovial giant cell tumor (TGCT) occurs most commonly in the appendicular skeleton and is only rarely found in the vertebral column. Lesions of the craniocervical junction are particularly rare, with only 4 cases reported in the literature. The authors describe the case of a diffuse-type TGCT at the craniocervical junction. OBSERVATIONS: A patient presented with a 1-year history of right-sided neck pain and bilateral neurological symptoms in the distribution of the right occipital nerve. A 20-mm homogeneously contrast-enhancing mass in the suboccipital and posterior C1 region was discovered on magnetic resonance imaging of the cervical spine. The tumor was operated on via a posterior approach, and gross-total resection (GTR) was achieved. Immunohistochemical (IHC) examination revealed a diffuse-type TGCT. The patient had an uneventful recovery. LESSONS: TGCT can arise at the craniocervical junction and is easily misdiagnosed because of its rare occurrence. IHC examination of a tumor specimen should be done to confirm the diagnosis. GTR is the objective when treating these tumors, especially when they are the diffuse type, as they have a high recurrence rate. Radiation and small-molecule therapies are viable postoperative therapies if GTR cannot be achieved or in cases of recurrence. American Association of Neurological Surgeons 2023-08-28 /pmc/articles/PMC10555556/ /pubmed/37728324 http://dx.doi.org/10.3171/CASE23288 Text en © 2023 The authors https://creativecommons.org/licenses/by-nc-nd/4.0/CC BY-NC-ND 4.0 (http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) ) |
spellingShingle | Case Lesson Porto, Carl Ayala, Cameron Feler, Joshua Santos-Fontanez, Santos Poggi, Jonathan Kritselis, Michael Doberstein, Curtis Diffuse-type tenosynovial giant cell tumor between the suboccipital bone and posterior C1 arch: illustrative case |
title | Diffuse-type tenosynovial giant cell tumor between the suboccipital bone and posterior C1 arch: illustrative case |
title_full | Diffuse-type tenosynovial giant cell tumor between the suboccipital bone and posterior C1 arch: illustrative case |
title_fullStr | Diffuse-type tenosynovial giant cell tumor between the suboccipital bone and posterior C1 arch: illustrative case |
title_full_unstemmed | Diffuse-type tenosynovial giant cell tumor between the suboccipital bone and posterior C1 arch: illustrative case |
title_short | Diffuse-type tenosynovial giant cell tumor between the suboccipital bone and posterior C1 arch: illustrative case |
title_sort | diffuse-type tenosynovial giant cell tumor between the suboccipital bone and posterior c1 arch: illustrative case |
topic | Case Lesson |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555556/ https://www.ncbi.nlm.nih.gov/pubmed/37728324 http://dx.doi.org/10.3171/CASE23288 |
work_keys_str_mv | AT portocarl diffusetypetenosynovialgiantcelltumorbetweenthesuboccipitalboneandposteriorc1archillustrativecase AT ayalacameron diffusetypetenosynovialgiantcelltumorbetweenthesuboccipitalboneandposteriorc1archillustrativecase AT felerjoshua diffusetypetenosynovialgiantcelltumorbetweenthesuboccipitalboneandposteriorc1archillustrativecase AT santosfontanezsantos diffusetypetenosynovialgiantcelltumorbetweenthesuboccipitalboneandposteriorc1archillustrativecase AT poggijonathan diffusetypetenosynovialgiantcelltumorbetweenthesuboccipitalboneandposteriorc1archillustrativecase AT kritselismichael diffusetypetenosynovialgiantcelltumorbetweenthesuboccipitalboneandposteriorc1archillustrativecase AT dobersteincurtis diffusetypetenosynovialgiantcelltumorbetweenthesuboccipitalboneandposteriorc1archillustrativecase |